SLS 22RS-435 ENGROSSED
2022 Regular Session
SENATE BILL NO. 257
BY SENATOR FRED MILLS
MEDICAID. Provides relative to Medicaid coverage for continuous glucose monitors.
(8/1/22)
1 AN ACT
2 To enact R.S. 46:450.8, relative to Medicaid coverage for continuous glucose monitors; to
3 require Medicaid coverage for continuous glucose monitors; to provide for the
4 method of coverage; to provide for duties of the Louisiana Department of Health;
5 and to provide for related matters.
6 Be it enacted by the Legislature of Louisiana:
7 Section 1. R.S. 46:450.8 is hereby enacted to read as follows:
8 ยง450.8. Continuous glucose monitors; Medicaid coverage
9 A. Except as provided in Subsection B of this Section, the Louisiana
10 Medicaid program shall provide coverage for a continuous glucose monitor for
11 the treatment of an enrollee who has one of the following conditions:
12 (1) Any type of diabetes with the use of insulin more than two times
13 daily or evidence of level 2 or level 3 hypoglycemia.
14 (2) Glycogen storage disease type 1a.
15 B. To qualify for coverage pursuant to Subsection A of this Section, the
16 enrollee shall attend regular follow-up visits with a healthcare provider at a
17 minimum of every six months to assess the ongoing benefit of the enrollee's use
Page 1 of 2
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 257
SLS 22RS-435 ENGROSSED
1 of a continuous glucose monitor.
2 C.(1) The Louisiana Department of Health shall implement the
3 provisions of this Section using the most cost-effective solution available to the
4 department.
5 (2) The secretary of the department shall submit to the Centers for
6 Medicare and Medicaid Services all state plan amendments, promulgate all
7 rules and regulations in accordance with the Administrative Procedure Act, and
8 take any other actions necessary to implement the provisions of this Section.
9 D. For the purposes of this Section, "continuous glucose monitor" means
10 an instrument or device, including repair and replacement parts, that is
11 designed and offered for the purpose of measuring glucose levels at set intervals
12 by means of a small electrode placed under the skin and held in place by an
13 adhesive.
The original instrument and the following digest, which constitutes no part
of the legislative instrument, were prepared by Brandi Cannon.
DIGEST
SB 257 Engrossed 2022 Regular Session Fred Mills
Proposed law requires the La. Medicaid program to provide coverage for a continuous
glucose monitor for the treatment of an enrollee who has any type of diabetes with the use
of insulin more than two times daily or evidence of level 2 or level 3 hypoglycemia or who
has glycogen storage disease type 1a.
Proposed law requires an enrollee who receives coverage for a continuous glucose monitor
to attend regular follow-up visits with a healthcare provider at a minimum of every six
months to assess the ongoing benefit of the enrollee's use of a continuous glucose monitor.
Proposed law requires the La. Dept. of Health to implement the coverage requirement of
proposed law using the most cost-effective solution available to the department.
Effective August 1, 2022.
(Adds R.S. 46:450.8)
Page 2 of 2
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.